2023-2024年湖南省长沙市H3N2流感流行株血凝素蛋白鸡胚适应性关键突变研究

Study of key mutations of chicken embryo adaptation of HA protein of influenza A (H3N2) virus circulating in Changsha, Hunan, 2023–2024

  • 摘要:
    目的 本研究旨在分析2023—2024年湖南省长沙市H3N2亚型流感病毒在鸡胚中复制能力提高的分子机制,为疫苗株筛选提供依据。
    方法 选取2023—2024年长沙市H3N2流行期间6例流感样病例的H3N2核酸阳性样本,分别接种犬肾上皮细胞和无特定病原鸡胚进行病毒分离,通过红细胞凝集试验与凝集抑制试验鉴定病毒滴度。 采用Illumina测序平台对血凝素基因进行全长测序,使用MEGA 11.0软件用邻接法构建系统进化树,并通过多序列比对重点分析抗原决定簇及受体结合位点氨基酸突变,鉴定与鸡胚适应性相关的关键位点。
    结果 6株H3N2鸡胚毒株HA滴度为1∶8~1∶64,鸡胚一代分离阳性率83.33%。 进化分析显示2023—2024年长沙市H3N2流行株归属于3C.2a1b.2a.2a.3a.1谱系,与2023—2024年世界卫生组织推荐疫苗株序列一致性达99.10%~99.60%;与鸡胚生长不良型参考毒株HA蛋白序列比对分析发现了H156S、Y159N、G186D、F193S等与鸡胚内流感病毒发育适应相关的氨基酸突变位点。在鸡胚传代过程中,H3N2流感病毒出现了D186N、N246K两个鸡胚适应性突变,均不在抗原决定簇。
    结论 2023—2024年长沙市H3N2流行株通过HA蛋白受体结合域关键氨基酸位点突变,重新获得在鸡胚良好的生长复制能力;鸡胚适应性突变D186N、N246K对病毒抗原性影响有限。 本研究为疫苗生产株筛选提供了分子标记,但需持续监测这些突变对病毒传播力及疫苗有效性的潜在影响。

     

    Abstract:
    Objective To analyze the molecular mechanism of the improved replication of influenza A (H3N2) virus in chicken embryos during 2023-2024 in Changsha, Hunan province, and provide evidence for the screening of for vaccine strain.
    Methods The positive samples of influenza A (H3N2) virus nucleic acid of 6 influenza like illness (ILI) cases during the influenza A (H3N2) epidemic in Changsha from 2023 to 2024 were selected and inoculated into dog kidney epithelial cells and specific pathogen-free chicken embryos for virus isolation. The virus titer was identified by red blood cell agglutination test and agglutination inhibition test. The full-length sequence of hemagglutinin (HA) gene was sequenced by the Illumina sequencing platform. The phylogenetic tree was constructed with neighbor-joining method by using MEGA 11.0 software. The amino acid mutations of antigenic determinants and receptor binding sites were analyzed by multiple sequence alignment, and the key sites related to chicken embryo adaptability were identified.
    Results The HA titer of 6 H3N2 chicken embryo strains ranged from 1∶8 to 1∶64, and the positive rate of chicken embryo first-generation isolation was 83.33%. Phylogenetic analysis showed that the H3N2 epidemic strains in Changsha from 2023 to 2024 belonged to the 3C.2a1b.2a.2a.2a.3a.1 lineage and the sequence consistency with the vaccine strains recommended by World Health Organization from 2023 to 2024 was 99.10%−99.60%. Comparison with the HA protein sequence of the reference strain of chicken embryo dysplasia found H156S, Y159N, G186D, F193S and other amino acid mutation sites related to the development and adaptation of influenza virus in chicken embryos. In the passage in chicken embryos, H3N2 virus had two adaptive mutations of D186N and N246K in chicken embryos, which were not found in the antigenic determinant.
    Conclusion From 2023 to 2024, the H3N2 strain spread in Changsha regained good growth and replication in chicken embryos through mutation of key amino acid sites in the HA protein receptor binding domain. The adaptive mutation D186N and N246K in chicken embryo has limited effect on viral antigenicity. This study provides molecular marker for vaccine strain screening, but the potential impact of these mutations on viral transmissibility and vaccine efficacy needs continuous monitor.

     

/

返回文章
返回